So what happened is, all of a sudden now there is this information coming out to us that drug companies, or pharmaceutical companies, are able to extend their patents, I cannot even believe why, would extend the patents probably somewhere around 2 to 3 years, creating the idea that then the generic drug never becomes available for that long. And that also causes a problem because we could cut or look at the cost.
Discussing issues related to pharmaceutical patent extensions and their impact on drug availability and costs.
Share
More from Karen Thurman
Mr. Speaker, the Democratic Caucus drafted a balanced energy plan that was paid for, the Markey-Stenholm-Sandlin-Frost proposal, which should have had a chance to have been voted on today, but the House was denied the opportunity. My…
Yes. And we also correct a somewhat curious operation where they have actually kind of been involved or engaged with some generic companies where they actually have bought out or have actually delayed the generic drug coming to the market…
The gentlewoman brings up an excellent point, and it is a point that needs to be talked about even more. As we just did the tax bill, and we are watching all these dollars kind of go out there right now, which legitimately we all agree…
I stand today to say that I support the amendment offered by the gentleman from Florida (Mr. Davis). This is a project that, in fact, is going to be completed by this winter, about 753 miles long. The fact of the matter is that in my…
Other voices in this conversation
